Navigation Links
Biotech Family Reunion Meets in Illinois

CHICAGO Last Wednesday and Thursday, a biotech family reunion took place at Navy Pier in Chicago when IBIO, otherwise known as the Illinois Biotechnology Industry Organization, celebrated its fifth-annual event. The gathering was called iBIOMarketplace.

This event originally started in 1999 as the annual meeting of IBIOs predecessor orga......

Full article >>> ear for biotech and Chicagos economy, and even though the meeting looked like a biotech circus with three rings operating at the same time, attendance fell below expectations. It barely reached the 400 level. It was solid but still quite disappointing.

In retrospect, McCormick and the Hyatt were great for large groups of people coming from out of town, but for a local meeting, this site ......

Full article >>> thway to biotech growth in the region for the future. IBIOs chairman of the board for the year, James L. Tyree (a senior executive from Abbott Labs), also demonstrated the significant support by this company to biotech in Illinois.

I was very much swayed by Bruce Rauners powerful message of how GTCRs $6 billion in funds help build companies all over the U.S. and GTCRs unique style for as......

Full article >>> et cap of $258 billion, which isnt too far from the combined value of Pfizer and Merck (Big Pharmas largest companies). He also stated that the biotech industry has 130 drugs on the market and 350 drugs either awaiting FDA approval or in human clinical trials. He noted another trend: the appearance......

Full article >>> l the Baxter corporate culture a biotech culture. Still, this is one of Illinoiss largest health-care companies and I watch their moves assiduously.

iBIOMarketplace also featured presentations by about 20 biotech companies (public and private) mostly from the Midwest (one did come all the way from the Bay area and another came from India). These presentations were not only well attended;......

Full article >>> lace in the first part of 2004, which will hopefully provide an opportunity for VC money to exit long-held investments and renew their portfolios with new investments.

Seven biotech companies went public during the month between Oct. 8 and Nov. 6 raising $268 million, according to BioCentury. Most of the pricing of these IPOs was on the low end of the pricing range, which shows that the ......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 11/19/03


Related biology technology :

1. Biotech officials praise focus of new venture fund
2. Biotech executive books a career flight thats closer to home
3. Gala Biotech among companies sold for $3.3 billion
4. Biotech with Madison ties raises $21M in capital
5. Biotech firm uses live heart tissue in drug screens
6. Biotech talent drew venture-funded firm to Madison
7. Biotech firm has strokes, Alzheimers in its sights
8. 42 days until the 2006 Olympics of Biotechnology in Chicago
9. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
10. Biotech leads list of top U.S. companies to work for
11. Biotech flourishes in 2005 while Big Pharma is on the decline
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... June 27, 2016  Global demand for enzymes ... through 2020 to $7.2 billion.  This market includes ... cleaning products, biofuel production, animal feed, and other ... and biocatalysts). Food and beverages will remain the ... increasing consumption of products containing enzymes in developing ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... medical technologies, services and solutions to the healthcare market. The company's primary focus ... distribution, manufacturing, sales and marketing strategies that are necessary to help companies efficiently ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):